Z2M-22918-85094
1 vaccination
5 coded responses
10 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 930 / CA
- Registered
- 2021-04-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-24
Registered in v-safe
-
2021-04-24
Dose 1 — Pfizer-BioNTech
-
2021-04-24
Survey response — day 0, dose 1MedDRA: Anxiety — Feeling: FairFree text: AnxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-26
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Nausea, Abdominal painAdult check-in
-
2021-04-27
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Redness · Fever · Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-28
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Chills, Headache, Diarrhea, Abdominal pain · Be unable to workAdult check-in
-
2021-05-03
Health check-in — day 7, dose 1Feeling: Poor · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to workAdult check-in
-
2021-05-08
Survey response — day 14, dose 1MedDRA: Dysmenorrhoea, Heavy menstrual bleeding — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Super heavy period with major cramps like childbirthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-22
Survey response — day 28, dose 1MedDRA: Fatigue, Migraine — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Tired and migrainesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-24
Survey response — 3 months, dose 1MedDRA: Heavy menstrual bleeding — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Heavy periodsMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-04-26
Survey response — 12 months, dose 1MedDRA: Abortion spontaneous — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Miscarriage 2xMedDRA releases: 2024-11 · check-in free text available
-
2022-04-26
Report sent to call center — 12 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
- 2022-04-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-26 | Unsuccessful |
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Anxiety
Release 8 — day 14, dose 1
Symptoms: Super heavy period with major cramps like childbirth
Release 8 — day 28, dose 1
Symptoms: Tired and migraines
Release 9 — 3 months, dose 1
Symptoms: Heavy periods
Release 11 — 12 months, dose 1
Symptoms: Miscarriage 2x
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release